BCG revaccination does not protect against leprosy in the Brazilian Amazon: A cluster randomised trial

PLoS Neglected Tropical Diseases

Volumn 2, Issue 2, 2008, Pages

  Cunha, Sérgio S ^a   Alexander, Neal ^b   Barreto, Mauricio L ^a   Pereira, Emilia S ^c   Dourado, Inês ^a   Maroja, Maria de Fátima ^c   Ichihara, Yury ^d   Brito, Silvana ^a   Pereira, Susan ^a   Rodrigues, Laura C ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Fundacao Alfredo da Matta   (Brazil)

^d FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; ARTICLE; BCG VACCINATION; BRAZIL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CLUSTER ANALYSIS; COMMUNITY CARE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTERVENTION STUDY; LEPROSY; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; TUBERCULOSIS; CHILD; IMMUNOLOGY; VACCINATION;

ADOLESCENT; BCG VACCINE; BRAZIL; CHILD; FEMALE; HUMANS; INCIDENCE; LEPROSY; MALE; VACCINATION;

EID: 48949118017     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000167     Document Type: Article

References (32)

1. Fine PE (1996) Primary prevention of leprosy. Int J Lepr Other Mycobact Dis 64: S44-49.
2. Lombardi C, Pedrazzani ES, Pedrazzani JC, Filho PF, Zicker F (1996) Protective efficacy of BCG against leprosy in Sao Paulo. Bull Pan Am Health Organ 30: 24-30.
3. Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichiara MY, et al. (2005) Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC clustered-randomised trial. Lancet 366: 1290-1295.
4. Barreto ML, Rodrigues LC, Cunha SS, Pereira SM, Hijjar MA, et al. (2002) Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomised community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Control Clin Trials 23: 540-553.
5. Cunha SS, Dourado I, Barreto ML, Alexander N, Pereira SM, et al. (2004) Design of the leprosy component of the Brazlian BCG Revaccination trial for assessing BCG effectiveness against leprosy in schoolchildren. Int J Lepr Other Mycobact Dis 72: 8-15.
6. Karonga Prevention Trial Group (1996) Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348: 17-24.
7. Clemens J, Brenner R, Menng M, Tafari N, Lowe C (1996) Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA 275: 390-397.
8. Hayes RJ, Alexander NDE, Bennet S, Cousens SN (2000) Design and analysis issues in cluster-randomized trials on interventions against infectious diseases. Stat Method Med Research 9: 95-116.
9. Donner A, Klar N (2000) Design and analysis of cluster randomization trials in health research. London: Arnold.
10. Friedman LM, Furberg CD, DeMeters DL (1981) Fundamentals of clinical trials. Boston: John Wright.
11. Fine PE (1982) Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 4: 161-188.
12. Stanley SJ, Howland C, Stone MM, Sutherland I (1981) BCG vaccination of children against leprosy in Uganda: final results. J Hyg Lond 87: 233-248.
13. Bagshawe A, Scott GC, Russell DA, Wigley SC, Merianos A, et al. (1989) BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bull World Health Organ 67: 389-399.
14. Schulz KF, Grimes DA (2002) Allocation cancealment in randomised trials: defending against deciphering. Lancet 359: 614-618.
15. World Health Organization (1977) WHO expert committee on leprosy. World Health Organ Tech Rep Ser 607: 7-48.
16. World Health Organization (1988) WHO expert committee on leprosy. World Health Organ Tech Rep Ser 768: 35-36.
17. Ponnighaus JM, Fine PE, Bliss L (1987) Certainty levels in the diagnosis of leprosy. Int J Lepr Other Mycobact Dis 55: 454-462.
18. Assmann SE, Pocock SJ, Enos LE, Kasten LE (2000) Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355: 1064-1069.
19. Kirkwood BR, Sterne JAC (2003) Chapter 31. Analysis of clustered data. Essentials of Medical Statistics. Second ed: Blackwell Science Ltd. pp 355-370.
20. Cunha SS (2003) A Trial of BCG vaccine Effectiveness Against Leprosy Among School Children in Manaus, Northern Brazil [PhD thesis]. Landon: University of London. 221 p.
21. Clayton D, Hills M (1998) The size of investigations. In: Clayton D, Hills M, eds. Statistical models in epidemiology Oxford, UK: Oxford University Press. pp 206-213.
22. Cunha SS, Rodrigues LC, Pedrosa V, Dourado IM, Barreto ML, et al. (2004) Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Lepr Rev 75: 357-366.
23. Ministério da Saúde (2008) Brasil DATASUS. Available: http://w3.datasus.gov.br/datasus/datasus.php.
24. Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa, et al. (1998) Comparative leprosy vaccine trial in south India. Indian J Lepr 70: 369-388.
25. Lwin K, Sundaresan T, Gyi MM, Bechelli LM, Tamondong C, et al. (1985) BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull World Health Organ 63: 1069-1078.
26. Fine PE (1999) South Indian leprosy vaccine trial: important lessons for mycobacterial immunology. Lepr Rev 70: 247-249.
27. Gupte MD (2000) South India immunoprophylaxis trial against leprosy: relevance of findings in the context of trends in leprosy. Lepr Rev 71: S43-49.
28. Bertolli J, Pangi C, Frerichs R, Halloran ME (1997) A caw-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. Int J Epidemiol 26: 888-896.
29. Convit J, Smith PG, Zuniga M, Sampson C, Ulrich M, et al. (1993) BCG vaccination protects against leprosy in Venezuela: a case-control study. Int J Lepr Other Mycobact Dis 61: 185-191.
30. Setia MS, Steinmans C, Ho CS, Rutherford GW (2006) The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6: 162-170.
31. Barreto ML, Cunha SS, Pereira SM, Genser B, Hijjar MA, et al. (2005) Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int J Tuberc Lung Dis 9: 1171-1173.
32. Cunha SS, Rodrigues LC, Duppre NC (2004) Current strategy for leprosy control in Brazil: time to pursue alternative preventive strategies? Rev Panam Salud Publica 16: 362-365.